A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
Impact
The proposed legislation is expected to significantly improve the ability of visually impaired persons to manage their healthcare and medication regimens independently. By complying with established guidelines and the recommendations from the U.S. Government Accountability Office, the bill aims to set a standard for best practices around accessibility. This will likely lead to enhanced patient safety and adherence to medication protocols via informed decision-making and usage of accessible information.
Summary
Senate File 2022 seeks to enhance the accessibility of prescription-related information for individuals who are blind, have visual impairments, or other print disabilities. The bill mandates that the board of pharmacy implement administrative rules by October 31, 2024, ensuring that accessible prescription drug labels, bag tags, and medical guides are available. These measures are intended to provide necessary information in formats that are fully accessible and comparable in timeliness to that provided to sighted individuals, all at no additional cost to the affected individuals.
Contention
While the bill presents a positive shift towards inclusivity, it may face logistical challenges in its implementation. Concerns could arise regarding the costs associated with developing and maintaining these accessibility measures, as well as the potential need for additional training for pharmacy staff to comply with the new requirements. Moreover, there may be debates regarding the adequacy of input sought from individuals with disabilities in shaping these rules, with advocacy groups pushing for comprehensive involvement in the development process. Ultimately, the success of SF2022 will hinge on effectively balancing accessibility improvements with practicality in its execution.
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)
IA HF2456
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(Formerly HF 2252.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(Formerly HF 2252.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations
State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations
Pharmacist dispensing of prescriptions using an audible container or braille container label for patients who are visually impaired or blind requirement
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.